Home / BeCRO Live / Draft points to consider on implications of Coronavirus disease (COVID-19) on methodological aspects of ongoing clinical trialsDraft points to consider on implications of Coronavirus disease (COVID-19) on methodological aspects of ongoing clinical trials On 25th March, EMA issued a draft guidance for consultation with deadline for comments on 25th April. https://www.ema.europa.eu/en/documents/scientific-guideline/points-consider-implications-coronavirus-disease-covid-19-methodological-aspects-ongoing-clinical_en.pdf